Collection search

Filters

Found in: Library

Date: 2017

Publication type: Federal/National

Showing 51 - 75 of 80 filtered results

Per page:

Apply

51

No digital object

Cost pressures in the Canadian hospital drug market, 2006-2014 =Pressions sur les coûts du marché pharmaceutique des hôpitaux du Canada, 2006-2014.

Library / National Library Collections

Item ID number:

982389485

[2017]
52

No digital object

Private drug plans in Canada - cost drivers, 2008 to 2015 :Les facteurs de coût des régimes privés d'assurance-médicaments au Canada, de 2008 à 2015.

Library / National Library Collections

Item ID number:

982389492

[2017]
53

No digital object

Private drug plans in Canada - high-cost drugs and beneficiaries, 2005 to 2015 =Régimes privés d'assurance-médicaments au Canada - médicaments et bénéficiares à coûts élevés, de 2005 à 2015 ... [View full title] .

Library / National Library Collections

Item ID number:

982389494

[2017]
54

No digital object

Cost pressure of the new hepatitis C drugs in Canada =Pressions exercées sur les coûts des nouveaux médicaments contre l'hépatite C au Canada.

Library / National Library Collections

Item ID number:

982389496

[2017]
55

No digital object

The use of diabetes drugs in Canadian public drug plans =Utilisation des medicaments contre le diabete dans les regimes publics d'assurance-medicaments du Canada.

Library / National Library Collections

Item ID number:

1044484019

[2017]
56

No digital object

The use of diabetes drugs in Canadian public drug plans =Utilisation des médicaments contre le diabète dans les régimes publics d'assurance-médicaments du Canada.

Library / National Library Collections

Item ID number:

1059237269

[2017]
57

No digital object

Risk-Neutral Moment-Based Estimation of Affine Option Pricing Models /Bruno Feunou.

Library / National Library Collections

Item ID number:

1017570949

[2017]
58

No digital object

PMPRB guidelines scoping paper :high level overview of potential new framework : CGI consultation phase.

Library / National Library Collections

Item ID number:

1018285119

[Ottawa] :Patented Medicine Prices Review Board,[2017] [2017]
59

No digital object

Digital Transformation in the Service Sector :Insights from Consultations with Firms in Wholesale, Retail and Logistics /Wei Dong.

Library / National Library Collections

Item ID number:

1017587534

[2017]
60

No digital object

Banking regulation and market making /by David A. Cimon and Corey Garriott, Financial Markets Department, Bank of Canada.

Library / National Library Collections

Item ID number:

976416247

Cimon, David A, author.

[2017]
61

No digital object

Recent developments in the Canadian economy :spring 2017 /by Guy Gellatly and Elizabeth Richards.

Library / National Library Collections

Item ID number:

1036295443

Gellatly, Guy, author.

[2017]
62

No digital object

The share of systemic variations in the Canadian dollar - part II /by Jean-Sébastien Fontaine and Guillaume Nolin, Financial Markets Department, Bank of Canada.

Library / National Library Collections

Item ID number:

976416289

Fontaine, Jean-Sébastien, author.

[2017]
63

No digital object

Duvernay Shale economic resources.

Library / National Library Collections

Item ID number:

1018284359

[Calgary] :National Energy Board,2017. [2017]
64

No digital object

Private drug plans in Canada - cost drivers, 2008 to 2015 :Les facteurs de coût des régimes privés d'assurance-médicaments au Canada, de 2008 à 2015.

Library / National Library Collections

Item ID number:

982389493

[2017]
65

No digital object

Les prix de pétrôle et l'économie canadienne - événements et répercussions /Anil Arora, statisticien en chef du Canada.

Library / National Library Collections

Item ID number:

1021288959

Arora, Anil K, auteur.

[2017]
66

No digital object

Orphan Drug Launch Monitor (ODLM) =Observateur des médicaments orphelins (OMO).

Library / National Library Collections

Item ID number:

982389484

[2017]
67

No digital object

Cost pressures in the Canadian hospital drug market, 2006-2014 =Pressions sur les coûts du marché pharmaceutique des hôpitaux du Canada, 2006-2014.

Library / National Library Collections

Item ID number:

982389486

[2017]
68

No digital object

Développements récents de l'économie canadienne :quelle a été l'incidence du repli des prix du pétrole et de la dépréciation du dollar canadien sur l'économie du Canada? /Elizabeth Richards, ... [View full title] Direction des études analytiques.

Library / National Library Collections

Item ID number:

985966059

Richards, Elizabeth, 1984- auteur.

[2017]
69

No digital object

Private drug plans in Canada - high-cost drugs and beneficiaries, 2005 to 2015 =Régimes privés d'assurance-médicaments au Canada - médicaments et bénéficiares à coûts élevés, de 2005 à 2015 ... [View full title] .

Library / National Library Collections

Item ID number:

982389495

[2017]
70

No digital object

The use of diabetes drugs in Canadian public drug plans =Utilisation des médicaments contre le diabète dans les régimes publics d'assurance-médicaments du Canada.

Library / National Library Collections

Item ID number:

982389491

[2017]
71

No digital object

Protéger les Canadiens des prix excessifs des médicaments :consultation sur les modifications proposées au Règlement sur les médicaments brevetés.

Library / National Library Collections

Item ID number:

990233965

[2017]
72

No digital object

Cost pressure of the new hepatitis C drugs in Canada =Pressions exercées sur les coûts des nouveaux médicaments contre l'hépatite C au Canada.

Library / National Library Collections

Item ID number:

982389466

[2017]
73

No digital object

Document d'orientation sur les lignes directrices du CEPMB :aperçu de haut niveau du nouveau cadre éventuel : étape de consultation GCI.

Library / National Library Collections

Item ID number:

1021297022

Canada. Conseil d'examen du prix des médicaments brevetés, auteur, organisme de publication.

[2017]
74

No digital object

Concordance des listes de médicaments des régimes publics au Canada.

Library / National Library Collections

Item ID number:

1012850085

[2017]
75

No digital object

April 2017 annual reassessment of potential output growth in Canada /Andrew Agopsowicz, Bassirou Gueye, Natalia Kyui, Youngmin Park, Mohanad Salameh and Ben Tomlin, Canadian Economic Analysis Departme ... [View full title] nt, Bank of Canada.

Library / National Library Collections

Item ID number:

985965967

Agopsowicz, Andrew, author.

[2017]

First
Previous
Page of 4 Go
Next
Last

Looking for more? Try our other search tools:

Census search

Report a problem on this page

Date modified:: 2024-07-04

Language selection

Collection search

Collection search

Limited to

Limited to

Found in:

Library (80)

Date:

2010-2019 (80)

Publication type:

Format:

Available online :

Cost pressures in the Canadian hospital drug market, 2006-2014 =Pressions sur les coûts du marché pharmaceutique des hôpitaux du Canada, 2006-2014.

Private drug plans in Canada - cost drivers, 2008 to 2015 :Les facteurs de coût des régimes privés d'assurance-médicaments au Canada, de 2008 à 2015.

Private drug plans in Canada - high-cost drugs and beneficiaries, 2005 to 2015 =Régimes privés d'assurance-médicaments au Canada - médicaments et bénéficiares à coûts élevés, de 2005 à 2015 ... [View full title] .

Cost pressure of the new hepatitis C drugs in Canada =Pressions exercées sur les coûts des nouveaux médicaments contre l'hépatite C au Canada.

The use of diabetes drugs in Canadian public drug plans =Utilisation des medicaments contre le diabete dans les regimes publics d'assurance-medicaments du Canada.

The use of diabetes drugs in Canadian public drug plans =Utilisation des médicaments contre le diabète dans les régimes publics d'assurance-médicaments du Canada.

Risk-Neutral Moment-Based Estimation of Affine Option Pricing Models /Bruno Feunou.

PMPRB guidelines scoping paper :high level overview of potential new framework : CGI consultation phase.

Digital Transformation in the Service Sector :Insights from Consultations with Firms in Wholesale, Retail and Logistics /Wei Dong.

Banking regulation and market making /by David A. Cimon and Corey Garriott, Financial Markets Department, Bank of Canada.

Recent developments in the Canadian economy :spring 2017 /by Guy Gellatly and Elizabeth Richards.

The share of systemic variations in the Canadian dollar - part II /by Jean-Sébastien Fontaine and Guillaume Nolin, Financial Markets Department, Bank of Canada.

Duvernay Shale economic resources.

Private drug plans in Canada - cost drivers, 2008 to 2015 :Les facteurs de coût des régimes privés d'assurance-médicaments au Canada, de 2008 à 2015.

Les prix de pétrôle et l'économie canadienne - événements et répercussions /Anil Arora, statisticien en chef du Canada.

Orphan Drug Launch Monitor (ODLM) =Observateur des médicaments orphelins (OMO).

Cost pressures in the Canadian hospital drug market, 2006-2014 =Pressions sur les coûts du marché pharmaceutique des hôpitaux du Canada, 2006-2014.

Développements récents de l'économie canadienne :quelle a été l'incidence du repli des prix du pétrole et de la dépréciation du dollar canadien sur l'économie du Canada? /Elizabeth Richards, ... [View full title] Direction des études analytiques.

Private drug plans in Canada - high-cost drugs and beneficiaries, 2005 to 2015 =Régimes privés d'assurance-médicaments au Canada - médicaments et bénéficiares à coûts élevés, de 2005 à 2015 ... [View full title] .

The use of diabetes drugs in Canadian public drug plans =Utilisation des médicaments contre le diabète dans les régimes publics d'assurance-médicaments du Canada.

Protéger les Canadiens des prix excessifs des médicaments :consultation sur les modifications proposées au Règlement sur les médicaments brevetés.

Cost pressure of the new hepatitis C drugs in Canada =Pressions exercées sur les coûts des nouveaux médicaments contre l'hépatite C au Canada.

Document d'orientation sur les lignes directrices du CEPMB :aperçu de haut niveau du nouveau cadre éventuel : étape de consultation GCI.

Concordance des listes de médicaments des régimes publics au Canada.

April 2017 annual reassessment of potential output growth in Canada /Andrew Agopsowicz, Bassirou Gueye, Natalia Kyui, Youngmin Park, Mohanad Salameh and Ben Tomlin, Canadian Economic Analysis Departme ... [View full title] nt, Bank of Canada.

Collection search

Limited to

Limited to

Found in:

Library (80)

Date:

2010-2019 (80)

Publication type:

Format:

Available online :

Cost pressures in the Canadian hospital drug market, 2006-2014 =Pressions sur les coûts du marché pharmaceutique des hôpitaux du Canada, 2006-2014.

Private drug plans in Canada - cost drivers, 2008 to 2015 :Les facteurs de coût des régimes privés d'assurance-médicaments au Canada, de 2008 à 2015.

Private drug plans in Canada - high-cost drugs and beneficiaries, 2005 to 2015 =Régimes privés d'assurance-médicaments au Canada - médicaments et bénéficiares à coûts élevés, de 2005 à 2015 ... [View full title] .

Cost pressure of the new hepatitis C drugs in Canada =Pressions exercées sur les coûts des nouveaux médicaments contre l'hépatite C au Canada.

The use of diabetes drugs in Canadian public drug plans =Utilisation des medicaments contre le diabete dans les regimes publics d'assurance-medicaments du Canada.

The use of diabetes drugs in Canadian public drug plans =Utilisation des médicaments contre le diabète dans les régimes publics d'assurance-médicaments du Canada.

Risk-Neutral Moment-Based Estimation of Affine Option Pricing Models /Bruno Feunou.

PMPRB guidelines scoping paper :high level overview of potential new framework : CGI consultation phase.

Digital Transformation in the Service Sector :Insights from Consultations with Firms in Wholesale, Retail and Logistics /Wei Dong.

Banking regulation and market making /by David A. Cimon and Corey Garriott, Financial Markets Department, Bank of Canada.

Recent developments in the Canadian economy :spring 2017 /by Guy Gellatly and Elizabeth Richards.

The share of systemic variations in the Canadian dollar - part II /by Jean-Sébastien Fontaine and Guillaume Nolin, Financial Markets Department, Bank of Canada.

Duvernay Shale economic resources.

Private drug plans in Canada - cost drivers, 2008 to 2015 :Les facteurs de coût des régimes privés d'assurance-médicaments au Canada, de 2008 à 2015.

Les prix de pétrôle et l'économie canadienne - événements et répercussions /Anil Arora, statisticien en chef du Canada.

Orphan Drug Launch Monitor (ODLM) =Observateur des médicaments orphelins (OMO).

Cost pressures in the Canadian hospital drug market, 2006-2014 =Pressions sur les coûts du marché pharmaceutique des hôpitaux du Canada, 2006-2014.

Développements récents de l'économie canadienne :quelle a été l'incidence du repli des prix du pétrole et de la dépréciation du dollar canadien sur l'économie du Canada? /Elizabeth Richards, ... [View full title] Direction des études analytiques.

Private drug plans in Canada - high-cost drugs and beneficiaries, 2005 to 2015 =Régimes privés d'assurance-médicaments au Canada - médicaments et bénéficiares à coûts élevés, de 2005 à 2015 ... [View full title] .

The use of diabetes drugs in Canadian public drug plans =Utilisation des médicaments contre le diabète dans les régimes publics d'assurance-médicaments du Canada.

Protéger les Canadiens des prix excessifs des médicaments :consultation sur les modifications proposées au Règlement sur les médicaments brevetés.

Cost pressure of the new hepatitis C drugs in Canada =Pressions exercées sur les coûts des nouveaux médicaments contre l'hépatite C au Canada.

Document d'orientation sur les lignes directrices du CEPMB :aperçu de haut niveau du nouveau cadre éventuel : étape de consultation GCI.

Concordance des listes de médicaments des régimes publics au Canada.

April 2017 annual reassessment of potential output growth in Canada /Andrew Agopsowicz, Bassirou Gueye, Natalia Kyui, Youngmin Park, Mohanad Salameh and Ben Tomlin, Canadian Economic Analysis Departme ... [View full title] nt, Bank of Canada.

Pagination